患者报告症状能否用于评估系统性硬化症疾病活动度
该研究基于澳大利亚硬皮病队列的1636例系统性硬化症(SSc)患者,采用广义估计方程分析患者报告的症状加重与相应器官系统疾病活动特征之间的关联。结果显示患者报告的雷诺现象加重、皮肤受累加重和呼吸困难加重与数字溃疡、MRSS升高、肺功能恶化、新发ILD和PAH均显著相关,提示在缺乏客观指标时患者报告症状可用于提示SSc疾病活动度变化。
要点
- 患者报告雷诺现象加重与数字溃疡存在显著关联(OR 1.53)。
- 患者报告皮肤受累加重与MRSS升高显著相关(OR 2.10)。
- 患者报告呼吸困难加重与FVC下降、DLco下降、新发ILD及PAH均显著相关。
核心结论
- 患者报告症状与SSc临床有意义的疾病活动度变化相关。
- 在缺乏客观疾病状态变化指标时,患者报告症状可用于提示SSc疾病活动度变化。
研究设计与样本
- 基于澳大利亚硬皮病队列研究1636例患者的队列分析。
- 采用广义估计方程分析患者报告症状加重与相应器官系统疾病活动特征的关系。
主要发现
- 患者报告雷诺现象加重与数字溃疡显著相关(OR 1.53[95%CI 0.60-0.93])。
- 患者报告皮肤受累加重与MRSS升高显著相关(OR 2.10[95%CI 1.54-2.86])。
- 患者报告呼吸困难加重与FVC下降显著相关(OR 2.12[95%CI 1.70-2.65])。
- 患者报告呼吸困难加重与DLco下降显著相关(OR 1.97[95%CI 1.34-2.02])。
- 患者报告呼吸困难加重与新发ILD(OR 1.91[95%CI 1.40-2.61])及新发PAH(OR 5.08[95%CI 3.59-7.19])显著相关。
关键数值与推荐
- 患者报告雷诺现象加重与数字溃疡:OR 1.53(95%CI 0.60-0.93)。
- 患者报告皮肤受累加重与MRSS升高:OR 2.10(95%CI 1.54-2.86)。
- 患者报告呼吸困难加重与FVC下降:OR 2.12(95%CI 1.70-2.65);与DLco下降:OR 1.97(95%CI 1.34-2.02)。
- 患者报告呼吸困难加重与新发ILD:OR 1.91(95%CI 1.40-2.61);与新发PAH:OR 5.08(95%CI 3.59-7.19)。
临床怎么用
- 在无法获取客观疾病活动度指标时,可参考患者报告的雷诺现象、皮肤受累及呼吸困难加重来提示SSc疾病活动度变化。
- 对患者报告呼吸困难加重应警惕肺功能恶化、新发ILD或PAH的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association between patient-reported symptoms and changes in disease activity over time in systemic sclerosis (SSc). METHODS: Using data from 1,636 patients enrolled in the Australian Scleroderma Cohort Study, we used generalized estimating equations to determine the relationship between patient-reported worsening of Raynaud's phenomenon (RP), skin involvement, and breathlessness in the month preceding each study visit and features of disease activity in the corresponding organ systems. The associations between the following parameters were analyzed: patient-reported worsening RP and the presence of new-onset digital pitting and digital ulcers; patient-reported worsening skin involvement and increasing modified Rodnan skin thickness score (MRSS); new areas of skin involvement and new-onset joint contractures; patient-reported worsening breathlessness and deteriorating respiratory functions test (RFT) results, indicated by a 10% decrease in forced vital capacity (FVC) and a 15% decrease in diffusing capacity for carbon monoxide (DLco), new-onset interstitial lung disease (ILD), and new-onset pulmonary arterial hypertension (PAH). RESULTS: We found a significant association between patient-reported worsening RP and the presence of digital ulcers (odds ratio [OR] 1.53 [95% confidence interval (95% CI) 0.60-0.93]), patient-reported worsening skin involvement and increasing MRSS (OR 2.10 [95% CI 1.54-2.86]), and worsening patient breathlessness and deteriorating RFTs (FVC OR 2.12 [95% CI 1.70-2.65]; DLco OR 1.97 [95% CI 1.34-2.02]), new-onset ILD (OR 1.91 [95% CI 1.40-2.61]), and new-onset PAH (OR 5.08 [95% CI 3.59-7.19]). CONCLUSION: These results demonstrate that patient-reported symptoms are associated with clinically meaningful changes in disease activity in patients with SSc. This suggests that when objective measures of change in disease status are unavailable, patient-reported symptoms could be used to indicate a change in SSc disease activity.
引用
- Ross L, Stevens W, Wilson M, et al. Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis? Arthritis Care Res (Hoboken). 2020. PMID: 31421031. doi:10.1002/acr.24053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。